Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 28, 2008 at 1:43 PM EST

The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)

Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This…

Douglas A. McIntyre | Jan 24, 2008 at 4:19 PM EST

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Inc. (NASDAQ: AMGN) has announced earnings after the company released some positive data this morning. The troubled biotech giant…

Douglas A. McIntyre | Jan 24, 2008 at 7:04 AM EST

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Amgen Inc. (NASDAQ: AMGN) has announced the results of its biomarker analysis in new data that will be presented on…

Douglas A. McIntyre | Jan 23, 2008 at 8:39 AM EST

Pfizer’s Guidance Holding Up Better Than Skeptics Would Guess (PFE)

Pfizer Inc. (NYSE: PFE) has posted earnings that are lower than last year’s results, but were actually above analyst expectations…

Douglas A. McIntyre | Jan 23, 2008 at 7:33 AM EST

Does Martek Hold A Key To Treating Alzheimer’s Disease? (MATK)

Everyone knows about the current and future epidemic of Alzheimer’s Disease. This disease is largely untreated and most current treatments…

Douglas A. McIntyre | Jan 20, 2008 at 1:15 PM EST

Merck (MRK) Losing Out On OTC?

If a company like Merck (MRK) is going to overcome problems with a lot its drugs going "off patent" it…

Douglas A. McIntyre | Jan 17, 2008 at 3:37 AM EST

Drug Companies Cut Corners Again

Drug companies have put their fingers on the scales to make studies on the "effectiveness of a dozen popular antidepressants"…

Douglas A. McIntyre | Jan 15, 2008 at 7:07 PM EST

The Day In Biotech Stocks (January 15, 2008) (DNA, DNDN, GENZ, TTHI, LCBM, CEGE, GPCB, CGEN)

Today was a brutal day for risk stocks, and biotechs are often thought of as risky to stocks as Russian…

Douglas A. McIntyre | Jan 15, 2008 at 6:20 PM EST

Cramer’s Diagnostics Pick, Pet Blood & Urine… Really (IDXX)

On tonight’s MAD MONEY on CNBC, Jim Cramer came out calling for a move toward being ultra-defensive in what he…

Douglas A. McIntyre | Jan 15, 2008 at 10:07 AM EST

Will The E.U. Save Dendreon If The U.S. Won’t? (DNDN)

Dendreon Corp. (NASDAQ:DNDN) shares are trading up in early trading on a patent award, and that is after the fairly…

Douglas A. McIntyre | Jan 14, 2008 at 7:16 PM EST

Cramer’s Drug Research/CRO Stocks (CVD, PRXL)

On tonight’s MAD MONEY on CNBC, Jim Cramer came out with a positive tease early on in the contract research…

Douglas A. McIntyre | Jan 14, 2008 at 4:18 PM EST

Genentech Earnings Win, But Drugs Miss (DNA)

Genentech (NYSE: DNA) just announced its earnings were $0.69 EPS on $2.96 billion for the last quarter, and First Call…

Douglas A. McIntyre | Jan 14, 2008 at 3:02 PM EST

Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)

Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis…

Douglas A. McIntyre | Jan 14, 2008 at 12:33 PM EST

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS…

Douglas A. McIntyre | Jan 13, 2008 at 10:40 AM EST

Procter & Gamble (PG) NyQuil: Teenage Drug Of Choice

Getting high on cold mediciation appears to have become the "hot" path to a good time. And, it’s inexpensive and…

1 … 358 359 360 361 362 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Pfizer’s Guidance Holding Up Better Than Skeptics Would Guess (PFE)

Does Martek Hold A Key To Treating Alzheimer’s Disease? (MATK)

Merck (MRK) Losing Out On OTC?

Drug Companies Cut Corners Again

The Day In Biotech Stocks (January 15, 2008) (DNA, DNDN, GENZ, TTHI, LCBM, CEGE, GPCB, CGEN)

Cramer’s Diagnostics Pick, Pet Blood & Urine… Really (IDXX)

Will The E.U. Save Dendreon If The U.S. Won’t? (DNDN)

Cramer’s Drug Research/CRO Stocks (CVD, PRXL)

Genentech Earnings Win, But Drugs Miss (DNA)

Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Procter & Gamble (PG) NyQuil: Teenage Drug Of Choice

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Pfizer’s Guidance Holding Up Better Than Skeptics Would Guess (PFE)

Does Martek Hold A Key To Treating Alzheimer’s Disease? (MATK)

Merck (MRK) Losing Out On OTC?

Drug Companies Cut Corners Again

The Day In Biotech Stocks (January 15, 2008) (DNA, DNDN, GENZ, TTHI, LCBM, CEGE, GPCB, CGEN)

Cramer’s Diagnostics Pick, Pet Blood & Urine… Really (IDXX)

Will The E.U. Save Dendreon If The U.S. Won’t? (DNDN)

Cramer’s Drug Research/CRO Stocks (CVD, PRXL)

Genentech Earnings Win, But Drugs Miss (DNA)

Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Procter & Gamble (PG) NyQuil: Teenage Drug Of Choice

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%